Released on = May 4, 2007, 4:23 am

Press Release Author = Shushmul Maheshwari

Industry = Healthcare

Press Release Summary = Scientists from Argentina have cloned four cows, which they
claim will produce insulin in their milk.

Press Release Body = Argentine scientists claimed to have cloned four such cows
whose milk would contain human insulin. The scientists anticipate that if this
attempt is successful it’ll result in diminishing the costs of treatment for
diabetes, as reported by Reuters on April 17, 2007.

The cloned animals, which are still calves, are expected to begin producing \'insulin
infused’ milk on reaching adulthood.

Bio Sidus, the company spearheading the project, intends to launch a pharmaceutical
dairy where this new breed of cows can be accommodated in future. The objective is
to produce adequate amount of human insulin at a cost that’s lower than the
currently available insulin.

\"This model of a genetically modified cow allows us to produce large quantities of
products at very low cost,\" said Marcelo Criscuolo, managing director, in a
statement that Reuters published on April 17, 2007.

For producing pharmaceutical products such as insulin from the cow’s milk,
human gene of interest is inserted in to an embryo prior to placing it into a
surrogate mother cow. A gene for insulin was used in this case. After obtaining milk
from the cloned cows, it’ll be distilled and refined in order to extract
insulin. Human proteins have been produced in cows and goats using similar
techniques in the past as well.

Scientists are optimistic of the insulin produced in cows’ milk to hit the
market in a couple of years from now.

There’re approximately 200 million people suffering from diabetes across the
globe. According to Argentine scientists only 25 insulin producing cows would
suffice to meet the insulin demand of nearly 1.5 million diabetics in Argentina.

RNCOS report “New Developments in Insulin Delivery System (2006)”
notifies, “Current ambiance in insulin market comprises of strong marketing
combined with clinical advocacy supporting newer products. There has been a lot of
research and development done over the past 75 years for exploring alternative
routes for universal administration of insulin, however none of the systems so far
fully imitate insulin secretion’s physiology. The market for insulin delivery
should be US$ 2 Billion year on year. Growth should continue at the same rate or
more at least by 2020, when sales of insulin are estimated to surpass US$ 7.5
Billion.”

Key issues and facts analyzed in this report include: evaluation of current market
trends, scope of the major insulin delivery systems all over the world, analysis of
various challenges and opportunities before the industry, etc.

About RNCOS E-Services Pvt Ltd.:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM040.htm
Current Industry News: http://www.rncos.com/blog


Web Site = http://www.rncos.com

Contact Details = RNCOS E-Services Pvt Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com